“…3 As such, therapeutics that either regulate NOS activity or produce NO exogenously have become an important research area. Indeed, the number of scaffolds that chemically store and deliver NO include NO-releasing proteins, 4 nanoparticles, 5, 6 and polymers 7, 8 (see Nitric Oxide Release Part I: Macromolecular Scaffolds). These exogenous sources of NO have been investigated as potential medicinal agents for cardiovascular, 2, 9 cancer, 10 antibacterial, 11, 12 and wound healing 11, 13 therapies as discussed in Nitric Oxide Release Part II: Therapeutic Applications.…”